Felipe Dal-Pizzol

Dr. Felipe Dal-Pizzol

1. Graduate Program in Medical Sciences, Universidade do Extremo Sul Catarinense - Criciúma (SC), Brazil
+1
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
FVFlavio Protasio Veras
Flavio Protasio Veras
MPMarjorie Pontelli
Marjorie Pontelli
CSCamila Meirelles Silva
Camila Meirelles Silva
JTJuliana E. Toller-Kawahisa
Juliana E. Toller-Kawahisa
MLMikhael Haruo Fernandes Lima
Mikhael Haruo Fernandes Lima
FCFernando Queiroz Cunha
Fernando Queiroz Cunha
Severe COVID-19 patients develop acute respiratory distress syndrome that may progress to cytokine storm syndrome, organ dysfunction, and death. Considering that neutrophil extracellular traps (NETs) have been described as important mediators of tissue damage in inflammatory diseases, we investigated whether NETs would be involved in COVID-19 pathophysiology. A cohort of 32 hospitalized patients with a confirmed diagnosis of COVID-19 and healthy controls were enrolled. The concentration of NETs was augmented in plasma, tracheal aspirate, and lung autopsies tissues from COVID-19 patients, and their neutrophils released higher levels of NETs. Notably, we found that viable SARS-CoV-2 can directly induce the release of NETs by healthy neutrophils. Mechanistically, NETs triggered by SARS-CoV-2 depend on angiotensin-converting enzyme 2, serine protease, virus replication, and PAD-4. Finally, NETs released by SARS-CoV-2–activated neutrophils promote lung epithelial cell death in vitro. These results unravel a possible detrimental role of NETs in the pathophysiology of COVID-19. Therefore, the inhibition of NETs represents a potential therapeutic target for COVID-19.

6 January 2022 in Critical Care
Verified
Journal Article
Open access
PDF file
BTBarichello Tatiana
Barichello Tatiana
JGJaqueline S. Generoso
Jaqueline S. Generoso
MSMervyn Singer
Mervyn Singer
FDFelipe Dal-Pizzol
Felipe Dal-Pizzol
A biomarker describes a measurable indicator of a patient's clinical condition that can be measured accurately and reproducibly. Biomarkers offer utility for diagnosis, prognosis, early disease recognition, risk stratification, appropriate treatment (theranostics), and trial enrichment for patients with sepsis or suspected sepsis. In this narrative review, we aim to answer the question, "Do biomarkers in patients with sepsis or septic shock predict mortality, multiple organ dysfunction syndrome (MODS), or organ dysfunction?" We also discuss the role of pro- and anti-inflammatory biomarkers and biomarkers associated with intestinal permeability, endothelial injury, organ dysfunction, blood–brain barrier (BBB) breakdown, brain injury, and short and long-term mortality. For sepsis, a range of biomarkers is identified, including fluid phase pattern recognition molecules (PRMs), complement system, cytokines, chemokines, damage-associated molecular patterns (DAMPs), non-coding RNAs, miRNAs, cell membrane receptors, cell proteins, metabolites, and soluble receptors. We also provide an overview of immune response biomarkers that can help identify or differentiate between systemic inflammatory response syndrome (SIRS), sepsis, septic shock, and sepsis-associated encephalopathy. However, significant work is needed to identify the optimal combinations of biomarkers that can augment diagnosis, treatment, and good patient outcomes.

1 January 2010 in Critical Care Medicine
Verified
Journal Article
Closed access
MSMarcio Soares
Marcio Soares
PCPedro Caruso
Pedro Caruso
ESEliézer Silva
Eliézer Silva
JTJosé M. M. Teles
José M. M. Teles
SLSuzana M. A. Lobo
Suzana M. A. Lobo
JSJorge I. F. Salluh
Jorge I. F. Salluh
Objective: To evaluate the characteristics and outcomes of patients with cancer admitted to several intensive care units. Knowledge on patients with cancer requiring intensive care is mostly restricted to single-center studies. Design: Prospective, multicenter, cohort study. Setting: Intensive care units from 28 hospitals in Brazil. Patients: A total of 717 consecutive patients included over a 2-mo period. Interventions: None. Measurements and Main Results: There were 667 (93%) patients with solid tumors and 50 (7%) patients had hematologic malignancies. The main reasons for intensive care unit admission were postoperative care (57%), sepsis (15%), and respiratory failure (10%). Overall hospital mortality rate was 30% and was higher in patients admitted because of medical complications (58%) than in emergency (37%) and scheduled (11%) surgical patients (p < .001). Adjusting for covariates other than the type of admission, the number of hospital days before intensive care unit admission (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.01–1.37), higher Sequential Organ Failure Assessment scores (OR, 1.25; 95% CI, 1.17–1.34), poor performance status (OR, 3.40; 95% CI, 2.19 –5.26), the need for mechanical ventilation (OR, 2.42; 95% CI, 1.51–3.87), and active underlying malignancy in recurrence or progression (OR, 2.42; 95% CI, 1.51–3.87) were associated with increased hospital mortality in multivariate analysis. Conclusions: This large multicenter study reports encouraging survival rates for patients with cancer requiring intensive care. In these patients, mortality was mostly dependent on the severity of organ failures, performance status, and need for mechanical ventilation rather than cancer-related characteristics, such as the type of malignancy or the presence of neutropenia.

2 January 2023 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
PPPedro Póvoa
Pedro Póvoa
LCLuis Coelho
Luis Coelho
FDFelipe Dal-Pizzol
Felipe Dal-Pizzol
RFRicard Ferrer
Ricard Ferrer
AHAngela Huttner
Angela Huttner
AKAndre C. Kalil
Andre C. Kalil

1 October 2018 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
MNMartins Back Netto
Martins Back Netto
AJAloir Neri de Oliveira Junior
Aloir Neri de Oliveira Junior
MGMariana Goldim
Mariana Goldim
KMKhiany Mathias
Khiany Mathias
MFMaria Eduarda Fileti
Maria Eduarda Fileti
FPFabricia Petronilho
Fabricia Petronilho

1 May 2009 in Neurochemistry International
Verified
Journal Article
Closed access
GLGiancarlo Lucca
Giancarlo Lucca
CCClarissa M. Comim
Clarissa M. Comim
SVSamira S. Valvassori
Samira S. Valvassori
GRGislaine Z. Réus
Gislaine Z. Réus
FVFrancieli Vuolo
Francieli Vuolo
JQJoão Quevedo
João Quevedo